Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 18353889)

Published in Nephrol Dial Transplant on March 19, 2008

Authors

Georg Schlieper1, Mihail Hristov, Vincent Brandenburg, Thilo Krüger, Ralf Westenfeld, Andreas H Mahnken, Eray Yagmur, Georg Boecker, Nicole Heussen, Ulrich Gladziwa, Markus Ketteler, Christian Weber, Jürgen Floege

Author Affiliations

1: Department of Nephrology and Clinical Immunology, RWTH University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. gschlieper@ukaachen.de

Articles by these authors

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88

The genome of the protist parasite Entamoeba histolytica. Nature (2005) 5.33

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med (2007) 5.28

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. N Engl J Med (2015) 4.78

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal (2009) 4.73

Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol (2008) 4.20

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med (2002) 4.02

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest (2003) 3.71

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet (2003) 3.70

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology (2009) 3.20

JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol (2002) 3.17

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant (2010) 3.10

Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res (2010) 3.03

Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92

Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis (2011) 2.88

Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest (2010) 2.87

Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res (2007) 2.85

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78

Electrical forces determine glomerular permeability. J Am Soc Nephrol (2010) 2.74

Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation (2002) 2.69

Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation (2010) 2.69

Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res (2004) 2.68

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol (2005) 2.66

Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant (2010) 2.64

Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J (2007) 2.59

Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55

Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation (2007) 2.54

CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood (2008) 2.52

Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol (2008) 2.42

Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int (2008) 2.36

Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab (2010) 2.33

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation (2004) 2.30

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27

Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol (2006) 2.24

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23

Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 2.22

Heat stress response in plants: a complex game with chaperones and more than twenty heat stress transcription factors. J Biosci (2004) 2.22

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21

German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Value Health (2008) 2.20

Analysis of myocardial deformation based on ultrasonic pixel tracking to determine transmurality in chronic myocardial infarction. Eur Heart J (2006) 2.20

Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell (2013) 2.19

Role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation (2013) 2.18

Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med (2004) 2.17

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med (2009) 2.15

SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res (2005) 2.15

Neutrophil secretion products pave the way for inflammatory monocytes. Blood (2008) 2.12

Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol (2008) 2.12

Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12

Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science (2008) 2.10

Statin treatment after onset of sepsis in a murine model improves survival. Circulation (2005) 2.08

Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them? Nephrol Dial Transplant (2008) 2.05

Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest (2009) 2.01

Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2006) 1.99

Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant (2004) 1.99

Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol (2011) 1.95

Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol (2004) 1.94

Macrophage migration inhibitory factor in cardiovascular disease. Circulation (2008) 1.91

Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant (2010) 1.90

Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol (2010) 1.89

CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol (2009) 1.88

Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol (2007) 1.87

Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood (2010) 1.86

Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol (2009) 1.86

Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 1.85

Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci U S A (2011) 1.85

Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med (2011) 1.84

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care (2011) 1.84

Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res (2004) 1.84

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant (2010) 1.83

Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81

Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res (2013) 1.80

Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol (2011) 1.80

Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation. Blood (2013) 1.80

MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest (2012) 1.77

Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int (2005) 1.77

Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients. Am J Kidney Dis (2011) 1.74

Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J Nucl Med (2004) 1.72

Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J (2010) 1.72

Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation (2012) 1.71

Tetrameric organization of vertebrate centromeric nucleosomes. Proc Natl Acad Sci U S A (2010) 1.69

Fetuin-A regulation of calcified matrix metabolism. Circ Res (2011) 1.69

Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet (2012) 1.69

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med (2010) 1.68

Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol (2005) 1.63

Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol (2012) 1.63

Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J Mol Med (Berl) (2003) 1.63

Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int (2005) 1.63

A new algorithm for metal artifact reduction in computed tomography: in vitro and in vivo evaluation after total hip replacement. Invest Radiol (2003) 1.62